| Net Cash Provided by (Used in) Operating Activities |
$1,835,210,000 |
USD |
3.8% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,364,538,000 |
USD |
-37% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
4,500,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q2 2024 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$470,672,000 |
USD |
-290% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$736,554,000 |
USD |
-27% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$294,180,000 |
USD |
86% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
0 |
shares |
|
Q2 2024 |
FY 2025 |
| Additional Paid in Capital |
$19,856,584,000 |
USD |
40% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$973,473,000 |
USD |
22% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q2 2024 |
FY 2025 |